Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs ...

Most people infected by the hepatitis C virus (HCV) can be cured with antiviral therapy, but access to the treatment remains limited. Even diagnosis of hepatitis C, a disease that causes chronic ...

Around 300,000 people die from hepatitis C every year. A new study has mapped the protein complex that enables the virus to infect our cells, potentially paving the way for an effective vaccine.

In a study published in Scientific Reports, researchers from Spain developed a method to design vaccines for highly variable viruses like the hepatitis C virus (HCV) using combinatorial optimization.

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...